Sort
34,240 grants matching “atherosclerosis”
Pharmacogenetics of the human prostacyclin receptor.
$413,750John Hwa · Yale University · R01 · FY2010 · HL
Xanthine oxidase inhibition raises intracellular purines to activate AMPK, improve glucose control and decrease fatty liver and atherosclerosis in type 2 diabetes
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2017 · DK
PPAR-Mediated Inhibition of Vascular Remodeling
$413,750Alfred Lm Bothwell · Yale University · R01 · FY2010 · HL
Intrinsic anti-inflammatory actions of AMPK activation rendered through a novel immunometabolic AMPK-mTOR-NFkB Pathway
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2019 · HL
Thioredoxin and Endothelial Cell Function
$413,750Wang Min · Yale University · R01 · FY2009 · HL
Intrinsic anti-inflammatory actions of AMPK activation rendered through a novel immunometabolic AMPK-mTOR-NFkB Pathway
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2018 · HL
Molecular Models of Immune-mediated Vascular Injury
$413,750Jeffrey R. Bender · Yale University · R01 · FY2011 · HL
Pharmacogenetics of the human prostacyclin receptor.
$413,750John Hwa · Yale University · R01 · FY2011 · HL
Thioredoxin and Endothelial Cell Function
$413,750Wang Min · Yale University · R01 · FY2011 · HL
Molecular Models of Immune-mediated Vascular Injury
$413,750Jeffrey R. Bender · Yale University · R01 · FY2009 · HL
PPAR-Mediated Inhibition of Vascular Remodeling
$413,750Alfred Lm Bothwell · Yale University · R01 · FY2009 · HL
Thioredoxin and Endothelial Cell Function
$413,750Wang Min · Yale University · R01 · FY2008 · HL
Thioredoxin and Endothelial Cell Function
$413,750Wang Min · Yale University · R01 · FY2010 · HL
Phosphorylation and Endothelial Nitric Oxide Production
$413,750William C. Sessa · Yale University · R01 · FY2010 · HL
Intrinsic anti-inflammatory actions of AMPK activation rendered through a novel immunometabolic AMPK-mTOR-NFkB Pathway
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2016 · HL
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation
$413,750Kathleen Ann Martin · Yale University · R01 · FY2011 · HL
Xanthine oxidase inhibition raises intracellular purines to activate AMPK, improve glucose control and decrease fatty liver and atherosclerosis in type 2 diabetes
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2016 · DK
Phosphorylation and Endothelial Nitric Oxide Production
$413,750William C. Sessa · Yale University · R01 · FY2009 · HL
Systematic Investigation of Blacks with Stroke - Genomics (SIBS-Genomics) Study
$413,719Mayowa Ojo Owolabi · College Of Medicine, University Of Ibadan · R01 · FY2019 · NS
Project 4: Impact of cardiovascular disease on proliferation and genetic diversity of hematopoietic stem cells
$413,665Kamila Naxerova · Massachusetts General Hospital · P01 · FY2021 · HL
Zebrafish models of vascular inflammation and atherosclerosis
$413,647Yury Miller · University Of California, San Diego · R01 · FY2014 · HL
Molecular Models of Immune-mediated Vascular Injury
$413,645Jeffrey R. Bender · Yale University · R01 · FY2008 · HL
RAS and Injury
$413,617Kenneth E Bernstein · Cedars-Sinai Medical Center · R01 · FY2014 · HL
Role of Chlamydia Pneumoniae in Atherosclerosis
$413,560University Of Washington · R01 · FY2004 · HL
Cardioprotective Mechanisms of HDL
$413,525Jay W Heinecke · University Of Washington · R01 · FY2013 · HL